Village Green: Cannabis Daily Intelligence Brief
Friday, May 22, 2026 | 7:30 AM ET
Curated from social media posts and threads
🚨
Market Moves & Trading
Curaleaf Holdings Drops 13% in Market Selloff
Curaleaf (CURLF), the largest US MSO by market presence, tumbled 13.35% to $3.41 on Friday amid broad sector selling. 29 of 38 tracked cannabis stocks closed lower; MSOS ETF fell 8.88%. Pressure spans all operators as rescheduling timeline remains unclear.
Source: Business of Cannabis
Green Thumb Industries Reports Strong Q1 2026 Results
Green Thumb Industries (GTBIF) posted solid Q1 financials with wider margins and stronger balance sheet positioning. Stock rose 35% YTD. Analysts note GTI is better positioned than Curaleaf for DEA rescheduling benefits due to operational efficiency.
Source: Seeking Alpha
Ascend Wellness Plummets 17% in Steepest Single-Day Decline
Ascend Wellness Holdings (AAWH), a northeastern US operator, crashed 17.34% to $0.47—the session’s sharpest decline. No company-specific catalyst cited. Smaller-cap operators facing disproportionate selling pressure amid market uncertainty.
Source: Business of Cannabis
⚖️
Regulatory & Policy
DEA Opens Federal Registration for State-Licensed Dispensaries
Following the April 22 DOJ rescheduling order, the DEA opened a 60-day federal registration window for state-licensed medical marijuana dispensaries. June 22 deadline to file for protected operating status during federal review. Schedule III benefits immediately lift Section 280E tax restrictions for qualifying medical operators.
Source: Holland & Hart Law Firm
280E Tax Dispute Intensifies: New Mexico Top Organics vs. IRS
New Mexico Top Organics filed reply brief in ongoing 280E challenge, leveraging DOJ’s April 2026 rescheduling order to bolster arguments for tax deduction rights. Meanwhile, DOJ sued to claw back $8.36M refund from TerrAscend over 280E taxation dispute. High-stakes year for operator tax policy.
Source: Holland & Hart Law Firm
Virginia Governor Rejects Adult-Use Retail Bill
Virginia Governor Spanberger vetoed retail marijuana market bill despite campaign pledge. Delays progress on adult-use market expansion in the state. Follows weeks of legislative negotiations around licensing and social equity provisions.
Source: VPM News
📰
Industry News & Milestones
FDA Grants Breakthrough Status to Cannabis-Based Chronic Pain Drug
FDA designated a cannabis-based pharmaceutical for chronic back pain as “Breakthrough Therapy”—expediting approval timeline. Signals regulatory shift toward cannabinoid therapeutics. Positive catalyst for clinical-stage cannabis biotech companies.
Source: Cannabis.se
Louisiana Passes Bill Jailing Smokers Near College Campuses
Louisiana passed legislation creating jail time for cannabis consumption near college campuses, sending bill to governor’s desk. Reflects ongoing state-level patchwork of restrictive policies even as federal rescheduling progresses.
Source: Marijuana Moment / Reddit
Texas Rescores Medical Marijuana Licenses, Flips Winners
Texas rescored its medical marijuana license applications, changing which companies received conditional licenses. Reshuffles competitive landscape in one of nation’s largest emerging medical cannabis markets.
Source: Holland & Hart Law Firm
Hemp Market Tightens: Alaska Enforces New Restrictions
Alaska enforced new hemp restrictions as states tighten regulations on hemp-derived products amid THC potency concerns. Target rolls out THC beverages to 300+ stores nationwide—mainstream retail expansion accelerates.
Source: Holland & Hart Law Firm
💡 What’s Moving the Market
The Big Picture: Sector-wide selling pressure overshadows strong regulatory progress. Schedule III rescheduling lifts 280E burdens for medical operators, but uncertainty over timeline and federal enforcement details is driving broad-based declines. Smaller operators most vulnerable; larger MSOs with stronger balance sheets (GTI, AFC) show relative resilience.